BUSHRA NABI

Employment

• SUN PHARMACEUTICALS PVT LTD TRAINEE
  2018 - 2018
• QuintilesIMS Pharmacovigilance Analyst
  2016 - 2017
• IMS Health Pharmacovigilance Analyst
  2015 - 2016

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (27)

• Riluzole-loaded nanoparticles to alleviate the symptoms of neurological disorders by attenuating oxidative stress
  Drug Development and Industrial Pharmacy 2020 DOI: 10.1080/03639045.2020.1730396
  +Save
• Role of nanocarriers in photodynamic therapy
  Photodiagnosis and Photodynamic Therapy 2020 DOI: 10.1016/j.pdpdt.2020.101782
  +Save
• Nano-based anti-tubercular drug delivery: an emerging paradigm for improved therapeutic intervention
  Drug Delivery and Translational Research 2020 DOI: 10.1007/s13346-020-00786-5
  +Save
• Harnessing nanotechnology for enhanced topical delivery of clindamycin phosphate
  Journal of Drug Delivery Science and Technology 2019 DOI: 10.1016/j.jddst.2019.101253
  +Save
• Insights on Oral Drug Delivery of Lipid Nanocarriers: a Win-Win Solution for Augmenting Bioavailability of Antiretroviral Drugs
  AAPS PharmSciTech 2019 DOI: 10.1208/s12249-018-1284-9
  +Save
• Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson’s disease treatment?
  Expert Opinion on Drug Delivery 2019 DOI: 10.1080/17425247.2019.1684895
  +Save
• Natural anti-inflammatory agents for the management of osteoarthritis
  Discovery and Development of Anti-inflammatory Agents from Natural Products 2019 DOI: 10.1016/B978-0-12-816992-6.00004-8
  +Save
• Natural antileprotic agents: A boon for the management of leprosy
  Discovery and Development of Therapeutics from Natural Products Against Neglected Tropical Diseases 2019 DOI: 10.1016/B978-0-12-815723-7.00009-2
  +Save
• Optimization of Nanostructured Lipid Carriers of Lurasidone Hydrochloride Using Box-Behnken Design for Brain Targeting: In Vitro and In Vivo Studies
  Journal of Pharmaceutical Sciences 2019 DOI: 10.1016/j.xphs.2019.05.001
  +Save
• Polysaccharide-based amorphous solid dispersions (ASDs) for improving solubility and bioavailability of drugs
  Polysaccharide Carriers for Drug Delivery 2019 DOI: 10.1016/B978-0-08-102553-6.00010-6
  +Save